Organigram Global (OGI) Total Current Liabilities (2018 - 2025)

Organigram Global (OGI) posted quarterly Total Current Liabilities of $91.7 million for Q3 2025, up 134.53% year-on-year from $39.1 million in Q3 2024, and up 134.53% on a QoQ basis from $39.1 million in Q3 2024.

Organigram Global (OGI) Total Current Liabilities (2018 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Total Current Liabilities for 8 consecutive years, with $91.7 million the latest figure, recorded in Q3 2025.

  • Quarterly Total Current Liabilities rose 134.53% year-over-year to $91.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $91.7 million (up 134.53% YoY) and the FY2025 annual result came in at $91.7 million, up 134.53% from the prior year.
  • Total Current Liabilities rose to $91.7 million in Q3 2025 per OGI's latest filing, from $39.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for OGI reached as high as $91.7 million in Q3 2025 and fell as low as $16.7 million in Q3 2023.
  • A 5-year average of $38.6 million and a median of $30.1 million in 2021 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities tumbled 82.21% — and 2025, when it surged 134.53%.
  • Year by year, Total Current Liabilities stood at $21.1 million in 2021, then jumped by 103.17% to $42.9 million in 2022, then plunged by 61.02% to $16.7 million in 2023, then surged by 133.61% to $39.1 million in 2024, then jumped by 134.53% to $91.7 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $91.7 million, $39.1 million, and $16.7 million for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 91.67 Mn
Sep 30, 2024 39.09 Mn
Sep 30, 2023 16.73 Mn
Aug 31, 2022 42.93 Mn
Aug 31, 2021 21.13 Mn
Feb 28, 2021 19.86 Mn
Nov 30, 2020 78.26 Mn
Aug 31, 2020 21.64 Mn
May 31, 2020 22.57 Mn
Feb 29, 2020 111.58 Mn
Aug 31, 2019 33.18 Mn
May 31, 2019 25.67 Mn
Aug 31, 2018 8.59 Mn